Literature DB >> 29326112

Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.

Giovanni Filardo1,2, Ralph J Damiano3, Gorav Ailawadi4, Vinod H Thourani5, Benjamin D Pollock1, Danielle M Sass1, Teresa K Phan1, Hoa Nguyen1, Briget da Graca2,6,7.   

Abstract

OBJECTIVES: Postoperative atrial fibrillation (AF) following coronary artery bypass graft surgery (CABG) is significantly associated with reduced survival, but poor characterisation and inconsistent definitions present barriers to developing effective prophylaxis and management. We sought to address this knowledge gap.
METHODS: From 2002 to 2010, 11 239 consecutive patients without AF underwent isolated CABG at five sites. Clinical data collected for the Society of Thoracic Surgeons (STS) Database were augmented with details on AF detected via continuous in-hospital ECG/telemetry monitoring to assess new-onset post-CABG AF (adjusted for STS risk of mortality); time to first AF; durations of first and longest AF episodes; total in-hospital time in AF; number of in-hospital AF episodes; operative mortality; stroke; discharge in AF; and length of stay (LOS).
RESULTS: Unadjusted incidence of new-onset post-CABG AF was 29.5%. Risk-adjusted incidence was 33.1% and varied little over time (P=0.139). Among 3312 patients with post-CABG AF, adjusted median time to first AF was 52 (IQR: 48-55) hours; mean (SD) duration of first and longest events were 7.2 (5.3,9.1) and 13.1 (10.4,15.9) hours, respectively, and adjusted median total time in AF was 22 (IQR: 18-26) hours. Adjusted rates of operative mortality, stroke and discharge in AF did not vary significantly over time (P=0.156, P=0.965 and P=0.347, respectively). LOS varied (P=0.035), but in no discernible pattern.
CONCLUSIONS: Each year, ~800 000 people undergo CABG worldwide; >264 000 will develop post-CABG AF. Onset is typically 2-3 days post-CABG and episodes last, on average, several hours. Effective prophylaxis and management is urgently needed to reduce associated risks of adverse outcomes. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  atrial fibrillation; coronary artery disease surgery; epidemiology

Mesh:

Year:  2018        PMID: 29326112     DOI: 10.1136/heartjnl-2017-312150

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation.

Authors:  Jordi Heijman; Azinwi Phina Muna; Tina Veleva; Cristina E Molina; Henry Sutanto; Marcel Tekook; Qiongling Wang; Issam H Abu-Taha; Marcel Gorka; Stephan Künzel; Ali El-Armouche; Hermann Reichenspurner; Markus Kamler; Viacheslav Nikolaev; Ursula Ravens; Na Li; Stanley Nattel; Xander H T Wehrens; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-07-30       Impact factor: 17.367

2.  Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting.

Authors:  Amar Taha; Susanne J Nielsen; Stefan Franzén; Mary Rezk; Anders Ahlsson; Leif Friberg; Staffan Björck; Anders Jeppsson; Lennart Bergfeldt
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

3.  Role of fibroblast growth factor-23 (FGF-23) in the prediction of postoperative atrial fibrillation after coronary artery bypass surgery.

Authors:  Kartik Pandurang Jadhav; Praveen Gopalakrishna Pai; Indu Nair; Sajitha Krishnan; Praveen Kerala Varma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-10

4.  Predictors of Postoperative Atrial Fibrillation after Beating-Heart Coronary Artery Bypass Surgery: Is Cardiopulmonary Bypass a Risk Factor?

Authors:  Yusuf Velioglu; Ahmet Yuksel
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

5.  Long Term Outcome of Postoperative Atrial Fibrillation After Cardiac Surgery-A Propensity Score-Matched Cohort Analysis.

Authors:  Jung-Chi Hsu; Chen-Yu Huang; Shu-Lin Chuang; Hsu-Yu Yu; Yih-Sharng Chen; Chih-Hsien Wang; Lian-Yu Lin
Journal:  Front Cardiovasc Med       Date:  2021-04-27

6.  Incidence of New Onset Atrial Fibrillation After Cardiovascular Surgery in Vietnam: Results From A Novel Screening Strategy.

Authors:  Linh Ngo; Thinh Duc; Ba Vu Van; KienTrung Hoang; Dzung Tien Le; Huu Cong Nguyen; Thuy Tran Nguyen; Ben Freedman; Nicole Lowres
Journal:  J Atr Fibrillation       Date:  2021-08-31

7.  Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Low Dose Trial.

Authors:  Ramzi A Tabbalat; Imad Alhaddad; Ayman Hammoudeh; Yousef S Khader; Hassan Abu Khalaf; Mohammad Obaidat; Jude Barakat
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

8.  Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events: A Systematic Review and Meta-analysis.

Authors:  Shaojie Chen; Willem-Jan Acou; Marcio G Kiuchi; Christian Meyer; Philipp Sommer; Martin Martinek; Alexandra Schratter; Bruno R Andrea; Zhiyu Ling; Shaowen Liu; Yuehui Yin; Gerhard Hindricks; Helmut Pürerfellner; Mitchell W Krucoff; Boris Schmidt; K R Julian Chun
Journal:  JAMA Netw Open       Date:  2019-05-03

9.  Early Versus Delayed Stroke After Cardiac Surgery: A Systematic Review and Meta-Analysis.

Authors:  Mario Gaudino; Mohammed Rahouma; Michele Di Mauro; Bobby Yanagawa; Ahmed Abouarab; Michelle Demetres; Antonino Di Franco; Mohammed J Arisha; Dina A Ibrahim; Massimo Baudo; Leonard N Girardi; Stephen Fremes
Journal:  J Am Heart Assoc       Date:  2019-06-19       Impact factor: 5.501

10.  New-onset atrial fibrillation and outcomes following isolated coronary artery bypass surgery: A systematic review and meta-analysis.

Authors:  Matthew Kerwin; Jonathan Saado; Jonathan Pan; Gorav Ailawadi; Sula Mazimba; Michael Salerno; Nishaki Mehta
Journal:  Clin Cardiol       Date:  2020-07-21       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.